Adacord 40 mg Pfs Injection 0.8 ml

Adacord 40 mg Pfs Injection 0.8 ml belongs to the class of monoclonal TNF (Tumor necrosis factor) inhibitors that help reduce signs and symptoms of autoimmune disorders. It is primarily used in the treatment of rheumatoid arthritis, ankylosing spondylitis, juvenile idiopathic arthritis, plaque psoriasis, and psoriatic arthritis. This medicine is also used in the treatment of Crohn’s disease, ulcerative colitis, hidradenitis suppurativa, and uveitis.

Adacord 40 mg Pfs Injection 0.8 ml consists of Adalimumab, which works by inhibiting the TNF-α and TNF-β binding to the cell surface, thereby making the TNF cytokine inactive. This helps reduce inflammation and pain caused by various autoimmune diseases.

Adacord 40 mg Pfs Injection 0.8 ml may cause certain side effects such as nausea, headache, back pain, upper respiratory tract infections, vision problems, dizziness, pale skin, numbness, chest pain, rash, and injection site reactions. Most of these side effects do not require medical attention or resolve over time. However, if these side effects persist for longer, please consult your doctor on priority. Adacord 40 mg Pfs Injection 0.8 ml is a parenteral medicine. It will be administered by a trained healthcare doctor. Hence, do not self-administer. Your physician will decide the dose and duration of the medicine based on the type and severity of the condition.

Adacord 40 mg Pfs Injection 0.8 ml should be avoided if you are allergic to any of its components.  Inform your doctor if you have any history of serious infections, tuberculosis, optimistic infections, cancer, alcoholic hepatitis, hepatitis B virus infection, heart failure, liver, heart, or kidney diseases, or a weak immune system, as it can worsen your health condition. Adacord 40 mg Pfs Injection 0.8 ml may cause dizziness, so drive only if you are alert and focused. Adacord 40 mg Pfs Injection 0.8 ml should not be given to children under two years of age as safety has not been established. Consult the doctor if you are pregnant or breastfeeding.

Adacord 40 mg Pfs Injection 0.8 ml is used in the treatment of autoimmune inflammatory diseases. The detailed uses of Adacord 40 mg Pfs Injection 0.8 ml are as follows:

• Treatment of Rheumatoid arthritis (RA): Adacord 40 mg Pfs Injection 0.8 ml reduces inflammation, joint pain, and stiffness in adults with moderate to severe RA, improving mobility and quality of life.
• Treatment of Juvenile idiopathic arthritis (JIA): Adacord 40 mg Pfs Injection 0.8 ml is used in children to control inflammation, relieve joint symptoms, and support normal growth and development.
• Treatment of Crohn’s disease: Adacord 40 mg Pfs Injection 0.8 ml treats moderate to severe Crohn’s disease in adults and children by reducing intestinal inflammation when other treatments fail.
• Treatment of Ulcerative colitis: Adacord 40 mg Pfs Injection 0.8 ml is indicated for adults and children with moderate to severe ulcerative colitis who are unresponsive to conventional therapy.
• Treatment of Ankylosing spondylitis: Adacord 40 mg Pfs Injection 0.8 ml helps manage chronic back pain and stiffness by reducing spinal inflammation in adults.
• Treatment of Psoriatic arthritis: Adacord 40 mg Pfs Injection 0.8 ml improves joint and skin symptoms in adults by decreasing swelling, pain, and the formation of psoriatic skin lesions.
• Treatment of Hidradenitis suppurativa: Adacord 40 mg Pfs Injection 0.8 ml is used in adults and adolescents to reduce painful lumps and inflammation in areas like the armpits and groin.
• Treatment of Uveitis: Adacord 40 mg Pfs Injection 0.8 ml treats non-infectious uveitis in adults and children by lowering eye inflammation and helping preserve vision.
• Treatment of Chronic plaque psoriasis: Adacord 40 mg Pfs Injection 0.8 ml is used in adults with moderate to severe plaque psoriasis to reduce red, scaly patches and improve skin appearance.

• Follow your doctor’s instructions on the dosage and timing of this medication to ensure safety.
• Adacord 40 mg Pfs Injection 0.8 ml will be administered by the doctor or healthcare professional.
• Do not self-administer.

Adacord 40 mg Pfs Injection 0.8 ml consists of Adalimumab, which belongs to the class of monoclonal TNF (Tumor necrosis factor) inhibitors. It works by inhibiting the TNF-α and TNF-β binding to the cell surface, thereby making the TNF cytokine inactive. This helps reduce inflammation and pain, redness, and inflammation (swelling) caused by various autoimmune diseases.

Adacord 40 mg Pfs Injection 0.8 ml should be avoided if allergic to it or any other components present. Inform your doctor if you have any history of serious infections, tuberculosis, optimistic infections, cancer, alcoholic hepatitis, hepatitis B virus infection, heart failure, liver, heart or kidney diseases, weak immune system, multiple sclerosis (nerve and muscle disease), or diabetes as it can worsen your health condition. Do not take live vaccines while being treated with Adacord 40 mg Pfs Injection 0.8 ml to prevent any serious consequences. Adacord 40 mg Pfs Injection 0.8 ml is not recommended for use in children below two years of age as safety and efficacy are not established. This medicine is not recommended for patients suffering from sepsis as it can worsen the condition.